About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RSV Observational Study 2 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01922648

RSV Observational Study 2

Respiratory Syncytial Virus (RSV) is a virus that causes chest infections. It is the single most important cause of severe respiratory illness in infants and young children, and severe RSV infection e...

Lead sponsor: University of Oxford•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Oxford

Age

0 - 6 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Parent or guardian is willing and able to give informed consent for participation in the study
•Age suitable for Group 1, 2 or 3 as defined in above (Section 6.2)
•Delivery at 36 weeks gestation or later
•Having a blood sample for clinical reasons

Exclusion Criteria

•Parent or guardian unable or unwilling to give informed consent for participation in the study
•Any impaired function of the immune system, by medication or pathological process, which could augment or impair the immune response to RSV
•Concurrent acute or chronic infection
•Any chronic illness which, in the opinion of the Investigator, may lead to incorrect or inaccurate immunology data
•History of immunoprophylaxis with Palivizumab
•Delivery prior to 36 weeks gestation

Related studies

RECRUITINGPhase 3

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease

NCT07220109 · Respiratory Syncytial Virus Infections

RECRUITINGPhase 2

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

NCT07092865 · Respiratory Syncytial Virus Infections

Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

NCT07239583 · Respiratory Syncytial Virus Infection, Respiratory Syncytial Virus Infections

Active Not RecruitingPhase 3

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

NCT06534892 · Respiratory Syncytial Virus Infections

Active Not RecruitingPhase 3

RSV Vaccine in Transplant Recipients

NCT06593210 · Vaccine Response Impaired, Respiratory Syncytial Virus Infections, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 10, 2018Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment35

Start dateJun 2013

Last updatedSep 10, 2018

Condition

Respiratory Syncytial Virus Infections

Locations shown

Oxford University Hopsitals NHS Trust

Oxford

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 10, 2018Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions